Yale Cancer Center posted on X about recent paper by Saba Maleki et al., titled “Cardiac adverse events after Chimeric Antigen Receptor (CAR) T cell therapies: an updated systematic review and meta-analysis” published on Cardio-Oncology Journal.
Authors: Saba Maleki, Zahra Esmaeili, Niloofar Seighali, Arman Shafiee, Sara Montazeri Namin, Mohammad Amin Tofighi Zavareh, Sima Shamshiri Khamene, Izat Mohammadkhawajah, Michael Nanna, Azin Alizadeh-asl, Jennifer M. Kwan, Kaveh Hosseini
“A new study with Jennifer Kwan showed insights into the association between cardiotoxicity in CAR T-cell therapy + the levels of brain natriuretic peptide (BNP), C-reactive protein (CRP), creatinine, and ferritin, and highlights specific biomarker trends in CAR T-cell therapy-related cardiotoxicity.”
Source: Yale Cancer Center/X